Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-005169
Filing Date
2025-08-14
Accepted
2025-08-14 12:43:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5055
  Complete submission text file 0001085146-25-005169.txt   6672
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081
Type: SCHEDULE 13G/A

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-56595 | Film No.: 251216517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)